Literature DB >> 2390685

Bradykinin-induced depolarization of primary afferent nerve terminals in the neonatal rat spinal cord in vitro.

P M Dunn1, H P Rang.   

Abstract

1. Application of bradykinin (BK) to the spinal cord of the neonatal rat evoked depolarizations which could be recorded via either the dorsal or ventral roots. However, responses recorded via the ventral root were abolished by removal of extracellular Ca2+ or the addition of Cd2+, while responses recorded via the dorsal root were unaffected. 2. The response recorded via the ventral root was inhibited by the substance P antagonist spantide, while responses recorded via the dorsal root were unaffected. 3. Depolarizations recorded via the dorsal root were concentration-dependent with an EC50 of 30 nM. These responses were not antagonized by the BK1 selective antagonist Leu8des-Arg9BK, but were antagonized by D-Arg0Hyp3Thi5,8D-Phe7BK with a pA2 of 6.8 +/- 0.6, which is similar to the values determined for other BK2-mediated responses. 4. Application of phorbol dibutyrate (PDBu) to the spinal cord also evoked a depolarization with respect to the dorsal root. This response to PDBu was enhanced by removal of extracellular Ca2+, while the response to BK was unaffected. 5. The potent protein kinase inhibitor staurosporine reduced the response to PDBu, but did not affect the response to BK. 6. These results suggest that BK by acting on BK2 receptors can depolarize the central terminals of primary afferent nerve fibres. This response to BK does not appear to be mediated via the activation of protein kinase C. The depolarization to BK recorded via the ventral root of the spinal cord is indirect and may be secondary to the action of BK on the primary afferent terminals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390685      PMCID: PMC1917772          DOI: 10.1111/j.1476-5381.1990.tb15863.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs.

Authors:  H A Martin; A I Basbaum; G C Kwiat; E J Goetzl; J D Levine
Journal:  Neuroscience       Date:  1987-08       Impact factor: 3.590

Review 2.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

3.  New synthetic antagonists of bradykinin.

Authors:  M Schachter; Y Uchida; D J Longridge; T Labedz; E T Whalley; R J Vavrek; J M Stewart
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

4.  Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat.

Authors:  O Laneuville; R Couture
Journal:  Eur J Pharmacol       Date:  1987-06-04       Impact factor: 4.432

5.  Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

Authors:  L R Steranka; D C Manning; C J DeHaas; J W Ferkany; S A Borosky; J R Connor; R J Vavrek; J M Stewart; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Polyphosphoinositide hydrolysis in endothelial cells and carotid artery segments. Bradykinin-2 receptor stimulation is calcium-independent.

Authors:  C K Derian; M A Moskowitz
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

7.  The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro.

Authors:  S J Marsh; C E Stansfeld; D A Brown; R Davey; D McCarthy
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

8.  Regulation of calcium homeostasis in sensory neurons by bradykinin.

Authors:  S A Thayer; T M Perney; R J Miller
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

9.  Bradykinin-induced transient accumulation of inositol trisphosphate in neuron-like cell line NG108-15 cells.

Authors:  K Yano; H Higashida; H Hattori; Y Nozawa
Journal:  FEBS Lett       Date:  1985-02-25       Impact factor: 4.124

10.  Identification of bradykinin in mammalian brain.

Authors:  D C Perry; S H Snyder
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

View more
  7 in total

Review 1.  Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes.

Authors:  João B Calixto; Rodrigo Medeiros; Elizabeth S Fernandes; Juliano Ferreira; Daniela A Cabrini; Maria M Campos
Journal:  Br J Pharmacol       Date:  2004-11-01       Impact factor: 8.739

2.  Inhibition of the M current in NG 108-15 neuroblastoma x glioma hybrid cells.

Authors:  S Schäfer; P Béhé; H Meves
Journal:  Pflugers Arch       Date:  1991-07       Impact factor: 3.657

3.  Intestinal afferent nerve sensitivity is increased during the initial development of postoperative ileus in mice.

Authors:  M H Mueller; M Karpitschka; B Xue; M S Kasparek; A Sibaev; J Glatzle; M E Kreis
Journal:  J Gastrointest Surg       Date:  2009-01-07       Impact factor: 3.452

4.  The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro.

Authors:  K A Maubach; D Grundy
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

5.  Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140.

Authors:  C G Heapy; J S Shaw; S C Farmer
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

6.  Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro.

Authors:  L Andreeva; H P Rang
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

7.  Sensitization of neonatal rat lumbar motoneuron by the inflammatory pain mediator bradykinin.

Authors:  Mouloud Bouhadfane; Attila Kaszás; Balázs Rózsa; Ronald M Harris-Warrick; Laurent Vinay; Frédéric Brocard
Journal:  Elife       Date:  2015-03-17       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.